{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:21Z","timestamp":1789002561784,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ81359"],"award-info":[{"award-number":["2026JJ81359"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02278-7","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:39:31Z","timestamp":1782319171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics in antibody-positive pediatric patients with immune-mediated necrotizing myopathy"],"prefix":"10.1186","volume":"52","author":[{"given":"Yiwen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3504-7943","authenticated-orcid":false,"given":"Ciliu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"4","key":"2278_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","volume":"17","author":"A Oldroyd","year":"2017","unstructured":"Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017;17(4):322\u20138.","journal-title":"Clin Med (Lond)"},{"key":"2278_CR2","doi-asserted-by":"crossref","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337\u2009\u2013\u200945.","DOI":"10.1016\/j.nmd.2004.02.006"},{"issue":"7","key":"2278_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, Shaham B, Weiss PF, Horkayne-Szakaly I, Targoff IN, Miller FW, Mammen AL, Childhood Myositis Heterogeneity Study Group. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017;69(7):1088\u201394.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2278_CR4","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group. October. 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 2016. Neuromuscul Disord. 2018;28(1):87\u201399.","DOI":"10.1016\/j.nmd.2017.09.016"},{"issue":"5","key":"2278_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"5","key":"2278_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/acr.24993","volume":"75","author":"W Jiang","year":"2023","unstructured":"Jiang W, Shi J, Yang H, Tian X, Yang H, Chen Q, Zhang L, Peng Q, Wang G, Lu X. Long-Term Outcomes and Prognosis Factors in Patients With Idiopathic Inflammatory Myopathies Based on Myositis-Specific Autoantibodies: A Single Cohort Study. Arthritis Care Res (Hoboken). 2023;75(5):1175\u201382.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"2278_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.nmd.2015.01.003","volume":"25","author":"W Li","year":"2015","unstructured":"Li W, Zheng Y, Zhang W, Wang Z, Xiao J, Yuan Y. Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study. Neuromuscul Disord. 2015;25(5):375\u201380.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"2278_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/keu422","volume":"54","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Liu L, Wang L, Xiao J, Wang Z, Lv H, Zhang W, Yuan Y. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. Rheumatology (Oxford). 2015;54(6):1017\u201324.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2278_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10067-020-05274-2","volume":"40","author":"Q Xu","year":"2021","unstructured":"Xu Q, Li QX, Bi FF, Duan HQ, Luo YB, Yang H. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies. Clin Rheumatol. 2021;40(2):613\u201324.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2278_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jhsa.2006.11.008","volume":"32","author":"MA James","year":"2007","unstructured":"James MA. Use of the Medical Research Council muscle strength grading system in the upper extremity. J Hand Surg Am. 2007;32(2):154\u20136.","journal-title":"J Hand Surg Am"},{"issue":"11","key":"2278_CR11","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/ard.2005.045690","volume":"65","author":"IM Bronner","year":"2006","unstructured":"Bronner IM, van der Meulen MF, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, Hoogendijk JE. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis. 2006;65(11):1456\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2278_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091\u20136.","journal-title":"Stroke"},{"key":"2278_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejrad.2017.02.010","volume":"89","author":"A Wangensteen","year":"2017","unstructured":"Wangensteen A, Tol JL, Roemer FW, et al. Intra- and interrater reliability of three different MRI grading and classification systems after acute hamstring injuries. Eur J Radiol. 2017;89:182\u201390.","journal-title":"Eur J Radiol"},{"issue":"1","key":"2278_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00330-022-09005-w","volume":"33","author":"L Minssen","year":"2023","unstructured":"Minssen L, Renoux J, Abar G, et al. Three-dimensional turbo spin-echo (TSE) MRI assessment of indirect acute muscle injuries in athletes: comparison with two-dimensional TSE MRI. Eur Radiol. 2023;33(1):587\u201394.","journal-title":"Eur Radiol"},{"key":"2278_CR15","doi-asserted-by":"publisher","first-page":"105363","DOI":"10.1016\/j.nmd.2025.105363","volume":"50","author":"MP Skolka","year":"2025","unstructured":"Skolka MP, Pinal-Fernandez I, Mammen AL, Liewluck T. Emerging atypical clinicopathological manifestations of immune-mediated necrotizing myopathy (IMNM). Neuromuscul Disord. 2025;50:105363.","journal-title":"Neuromuscul Disord"},{"key":"2278_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2025.03.002","volume":"167","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang M, Zhao Y, Zheng Y, Hao H, Gao F, Xiong H, Zhang W, Wang Z, Yuan Y. Pediatric Immune-Mediated Necrotizing Myopathy: A Single-Center Retrospective Cohort Study. Pediatr Neurol. 2025;167:33\u201341.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"2278_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63(3):713\u201321.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2278_CR18","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1212\/NXI.0000000000000096","volume":"2","author":"S Ramanathan","year":"2015","unstructured":"Ramanathan S, Langguth D, Hardy TA, Garg N, Bundell C, Rojana-Udomsart A, Dale RC, Robertson T, Mammen AL, Reddel SW. Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e96.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2278_CR19","doi-asserted-by":"publisher","first-page":"152759","DOI":"10.1016\/j.semarthrit.2025.152759","volume":"73","author":"TN Dinh","year":"2025","unstructured":"Dinh TN, Nunez SE, Gonzales KM, Tapia KL, Garcia EB, Fields RA, Muruganandam M, Emil NS, O\u2019Sullivan FX, Sibbitt WL Jr. Statin-associated immune-mediated necrotizing myopathy in Hispanic Americans. Semin Arthritis Rheum. 2025;73:152759.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2278_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2017;76(4):681\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2278_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.nmd.2014.06.436","volume":"24","author":"PM Rodr\u00edguez Cruz","year":"2014","unstructured":"Rodr\u00edguez Cruz PM, Luo YB, Miller J, Junckerstorff RC, Mastaglia FL, Fabian V. An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscul Disord. 2014;24(12):1025\u201335.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"2278_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52(2):189\u201395.","journal-title":"Muscle Nerve"},{"issue":"2","key":"2278_CR23","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.autrev.2021.102993","volume":"21","author":"G Merlonghi","year":"2022","unstructured":"Merlonghi G, Antonini G, Garibaldi M. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge. Autoimmun Rev. 2022;21(2):102993.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2278_CR24","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/rheumatology\/keac115","volume":"61","author":"AGS Oldroyd","year":"2022","unstructured":"Oldroyd AGS, Lilleker JB, Amin T, Aragon O, Bechman K, Cuthbert V, Galloway J, Gordon P, Gregory WJ, Gunawardena H, Hanna MG, Isenberg D, Jackman J, Kiely PDW, Livermore P, Machado PM, Maillard S, McHugh N, Murphy R, Pilkington C, Prabu A, Rushe P, Spinty S, Swan J, Tahir H, Tansley SL, Truepenny P, Truepenny Y, Warrier K, Yates M, Papadopoulou C, Martin N, McCann L, Chinoy H, British Society for Rheumatology Standards, Audit and Guidelines Working Group. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. Rheumatology (Oxford). 2022;61(5):1760\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2278_CR25","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1093\/rheumatology\/keaa371","volume":"60","author":"T Kishi","year":"2021","unstructured":"Kishi T, Warren-Hicks W, Bayat N, Targoff IN, Huber AM, Ward MM, Rider LG, with the Childhood Myositis Heterogeneity Study Group. Corticosteroid discontinuation, complete clinical response and remission in juvenile dermatomyositis. Rheumatology (Oxford). 2021;60(5):2134\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"7S1","key":"2278_CR26","doi-asserted-by":"publisher","first-page":"S745","DOI":"10.1016\/S0929-693X(25)00253-2","volume":"32","author":"S Fontaine-Carbonnel","year":"2025","unstructured":"Fontaine-Carbonnel S. Corticosteroid treatment in Duchenne muscular dystrophy. Arch Pediatr. 2025;32(7S1):S745\u201351.","journal-title":"Arch Pediatr"},{"issue":"5","key":"2278_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2013.5","volume":"9","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. 2013;9(5):265\u201376.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"2278_CR28","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/acr.25406","volume":"76","author":"K Sharf","year":"2024","unstructured":"Sharf K, Do T, Ghetie D, Choi D, Chahin N. Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy. Arthritis Care Res (Hoboken). 2024;76(11):1584\u201392.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"2278_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mus.28114","volume":"70","author":"J Suh","year":"2024","unstructured":"Suh J, Amato AA. Management of immune-mediated necrotizing myopathy. Muscle Nerve. 2024;70(2):166\u201372.","journal-title":"Muscle Nerve"},{"key":"2278_CR30","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.2147\/DDDT.S493923","volume":"18","author":"B Liu","year":"2024","unstructured":"Liu B, Zhao Y, Liu D, Li X, Ma Z, Yang Q. The Latest Progress in the Application of Telitacicept in Autoimmune Diseases. Drug Des Devel Ther. 2024;18:5811\u201325.","journal-title":"Drug Des Devel Ther"},{"key":"2278_CR31","doi-asserted-by":"publisher","unstructured":"Kang C, Blair HA. Ofatumumab: a review in relapsing forms of multiple sclerosis. Drugs. 2022;82(1):55\u201362. https:\/\/doi.org\/10.1007\/s40265-021-01650-7. Erratum in: Drugs. 2022;82(1):63.","DOI":"10.1007\/s40265-021-01650-7"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02278-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:57:33Z","timestamp":1789001853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02278-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7777355\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Xiangya Hospital of Central South University (202307148-2, Date of approval: March 6th, 2025) and conducted in accordance with the ethical standards outlined in the Declaration of Helsinki. Written informed consent was obtained from the legal guardians of all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The parents of all the participants signed the Institutional Informed Consent for the participation and the anonymous use of their children\u2019s clinical data for scientific purposes.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"137"}}